First, animal experiments in vivo showed that separately silencing VEGFA or VEGFC significantly reduced the number of tumor cells in lymph nodes from the MFSD4A-AS1-overexpressing mice group (Fig. 7A and B). This evidence concerns the gene VEGFA and neoplasm.